Name: Staphylococcus aureus Wichita
Creator: BacDive
License: https://creativecommons.org/licenses/by/4.0/

Strain identifier

BacDive ID: 14449

Type strain:

Species: Staphylococcus aureus

Strain Designation: Wichita

Culture col. no.: CCUG 15915, DSM 2569, ATCC 29213, WDCM 00131, JCM 2874, CCM 4223, CECT 794, CIP 103429, IFO 15035, LMG 10147, NBIMCC 3999, NBRC 15035, NCTC 12973

Strain history: CIP <- 1990, ATCC <- Micro-media Syst. Inc. <- E.H. Gerlach: strain Wichita

NCBI tax ID(s): 1280 (species)

SI-ID 4996

LMG 10147, CIP 103429, ATCC 29213, DSM 2569, CCUG 15915, JCM 2874, NCTC 12973, CCM 4223, CNCTC 5480, IFO 15035, LMD 90.24, CECT 794, CCRC 11863, NBIMCC 3999, NBRC 15035, NCCB 90024, BCRC 11863, NCIM 5022, ACM 4744, ACM 5066

Special Collections

Other strains from Staphylococcus aureus

Section

Staphylococcus aureus Wichita is a facultative anaerobe, spore-forming, Gram-positive human pathogen that was isolated from wound.

coccus-shaped
Gram-positive
spore-forming
facultative anaerobe
human pathogen
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Caryophanales*
	Family	*Staphylococcaceae*
	Genus	*Staphylococcus*
	Species	**Staphylococcus aureus**
	Full Scientific Name (LPSN)	Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)

Synonym

Staphylococcus aureus subsp. anaerobius

Information on morphological and physiological properties Morphology

[Ref.: #116609]	Gram stain	positive

[Ref.: #116609]	Cell shape	coccus-shaped

[Ref.: #116609]	Motility	no

[Ref.: #1123]	Type of hemolysis	beta
[Ref.: #1123]	Hemolysis ability	1
[Ref.: #1123]	Incubation period	1-2 days

[Ref.: #116609]	Hemolysis ability	1

Information on culture and growth conditions Culture and growth conditions

[Ref.: #1123]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #1123]

Culture medium growth

[Ref.: #1123]

Culture medium link

Medium recipe at MediaDive

[Ref.: #1123]

Culture medium composition

expand / minimize

[Ref.: #1123]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #1123]

Culture medium growth

[Ref.: #1123]

Culture medium link

Medium recipe at MediaDive

[Ref.: #1123]

Culture medium composition

expand / minimize

[Ref.: #36626]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #36626]

Culture medium growth

[Ref.: #36626]

Culture medium composition

expand / minimize

[Ref.: #116609]

Culture medium

CIP Medium 72

[Ref.: #116609]

Culture medium growth

[Ref.: #116609]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #1123]		growth	37 °C
[Ref.: #36626]		growth	30 °C
[Ref.: #67770]		growth	37 °C
[Ref.: #116609]		growth	10-37 °C
[Ref.: #116609]	no	growth	45 °C

Information on physiology and metabolism Physiology and metabolism

[Ref.: #116609]

Oxygen tolerance

facultative anaerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Test 10

Test 11

Reference

[Ref.: #1123]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
24
32
24
26-28
22
38
32
26-28
resistant0
48
30
24-26
24
22
18
28
28-30
26-28
22-24
6
8
22
14
6
22-24
22
32
26
32
28-30
28-30
32
resistant0
26
16
26-28

[Ref.: #1123]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
22
32-34
22
28
22
38
34
30
resistant0
48
30-32
28
24
24
20
28
28
28
30
resistant0
10
20
14
8
24
22-24
30
30
32-34
32
32
32
resistant0
26
18
28-30

[Ref.: #1123]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
12
26
16
20
14
30-32
24-26
22
resistant0
34
20
18
18
16
14-16
18
18
12-14
14-16
resistant0
6
16
10
resistant0
16
14-16
22
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #1123]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
10
24
12
16
12
28
22
22
resistant0
36
18
16
16
14
12
16
18
18
18
resistant0
8
14
12
6
16
14
18
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #1123]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
24
34
24
28
22
38
34
30
resistant0
48-50
30
28-30
22-24
24
20
28
28
28
26-28
resistant0
10
22
16
6-8
34
22
30-32
30
34
32-34
34
30
resistant0
28
16
28

[Ref.: #1123]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
22
32
22-24
26-28
22
38
34
30
resistant0
46-48
28-30
26-28
24
24
20
28
28
28
28
resistant0
10
20-22
16
8
32
20-22
30-32
30
32
30
32-34
28-30
resistant0
26
16
28

[Ref.: #1123]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
24
32
24
30
22
38
34
32
resistant0
50
32
30
24
24
18
30
30
26-28
26
resistant0
10
22
18
8
24
22
32
30
34
44
32
30
resistant0
26-28
16
30

[Ref.: #1123]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
24
32
26
28
24
38
34
30-32
resistant0
50
32-34
28-30
26
26
20
30
30
28-30
30
resistant0
10
22
18-20
10
26-28
24
34
30
36-38
48-50
34
34
resistant0
28
18
30

[Ref.: #1123]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
22
32
24
28
22
36-38
32
32
resistant0
48
30
26-28
24
24
18
28-30
30
28
28
resistant0
10-12
22
16
8
24
20
30
30
32
46
32
30
resistant0
26
16
28-30

[Ref.: #1123]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
24
30-32
24
28-30
22-24
38
34
30
resistant0
48
30
26
22-24
24
18
30
30
26-28
24-26
resistant0
10
22
18
10
24-26
20
28-30
28-30
34-36
36
30
32
resistant0
26
16
28-30

[Ref.: #1123]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
22
32-34
22
28
22
38
34
30
resistant0
48
30-32
28
24
24
20
28
28
28
30
resistant0
10
20
14
8
24
22-24
30
30
32-34
32
32
32
resistant0
26
18
28-30

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]

Ability of spore formation

yes Confidence in %100

[Ref.: #1123]

Observation

MRSA

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	arginine ChEBI	+	hydrolysis	* from API ID32STA
[Ref.: #68375]	cellobiose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-glucose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannitol ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-mannose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	D-ribose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	esculin ChEBI	-	hydrolysis	* from API ID32STA
[Ref.: #116609]	hippurate ChEBI	+	hydrolysis
[Ref.: #68375]	lactose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	maltose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68375]	N-acetylglucosamine ChEBI	+	fermentation	* from API ID32STA
[Ref.: #116609]	nitrate ChEBI	+	reduction
[Ref.: #116609]	nitrite ChEBI	-	reduction
[Ref.: #68375]	ornithine ChEBI	-	degradation	* from API ID32STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68375]	sucrose ChEBI	+	fermentation	* from API ID32STA
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic sensitivity	Antibiotic resistance
[Ref.: #116609]		0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)	no	yes

	Metabolite production	Metabolite	Production
[Ref.: #116609]		indole ChEBI	no
[Ref.: #68375]		acetoin ChEBI	yes	* from API ID32STA

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #68375]		acetoin ChEBI	+	* from API ID32STA

	Enzyme	Enzyme activity	EC number
[Ref.: #116609]	alcohol dehydrogenase	+	1.1.1.1
[Ref.: #68375]	alkaline phosphatase	+	3.1.3.1	* from API ID32STA
[Ref.: #116609]	amylase	-
[Ref.: #68375]	arginine dihydrolase	+	3.5.3.6	* from API ID32STA
[Ref.: #116609]	beta-galactosidase	+	3.2.1.23
[Ref.: #68375]	beta-glucosidase	-	3.2.1.21	* from API ID32STA
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA
[Ref.: #116609]	caseinase	-	3.4.21.50
[Ref.: #1123]	catalase	+	1.11.1.6
[Ref.: #116609]	catalase	+	1.11.1.6
[Ref.: #116609]	coagulase	+
[Ref.: #1123]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #116609]	DNase	+
[Ref.: #116609]	gamma-glutamyltransferase	-	2.3.2.2
[Ref.: #116609]	gelatinase	-
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #116609]	lecithinase	+
[Ref.: #116609]	lipase	+
[Ref.: #116609]	lysine decarboxylase	-	4.1.1.18
[Ref.: #116609]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #68375]	ornithine decarboxylase	-	4.1.1.17	* from API ID32STA
[Ref.: #116609]	oxidase	-
[Ref.: #116609]	tween esterase	-
[Ref.: #116609]	urease	+	3.5.1.5
	Only first 10 entries are displayed. Click here to see all.

Fatty acid profile

Metadata FA analysis

Reference

[Ref.: #46381]

Fatty acid	Percentage	ECL
C15:0 ANTEISO	55.1	14.711
C17:0 anteiso	17.4	16.722
C15:0 ISO	7.9	14.621
C18:2 ω6,9c/C18:0 ANTE	4.2	17.724
C17:0 iso	4.1	16.629
C18:0	2.4	18
C18:1 ω9c	1.9	17.769
C16:0	1.7	16
C19:0 ANTEISO	1.5	18.729
C16:0 iso	1.4	15.626
C20:2 ω6,9c	1.4	19.735
C14:0 ISO	0.6	13.618
C19:0 ISO	0.5	18.633

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #1123]	6300	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+/-	-	-
[Ref.: #1123]	5791	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+	-	-
[Ref.: #1123]	5792	+/-	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+/-	+	+	+	+	-	-
[Ref.: #1123]	5793	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	+	-	-
[Ref.: #1123]	5794	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+	-	-
[Ref.: #1123]	5795	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+	-	-
[Ref.: #1123]	5796	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+	-	-
[Ref.: #1123]	5797	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+/-	-	+	+	+	-	-
[Ref.: #1123]	6186	+	+	-	-	+	+	+	+	+	+	+	-	-	-	-	+	+	-	+	+/-	+	+	+	+	-	-
[Ref.: #1123]	6220	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+	+	+	+	-	-
[Ref.: #1123]	6253	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	-	-	+	+	+	-	-
[Ref.: #1123]	6351	+	+	-	-	+	+	+	+	+	+/-	+	-	-	-	+	+	-	-	+	+	+	+	+	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #1123]	Sample type/isolated from	wound

[Ref.: #46381]	Sample type/isolated from	Wound

[Ref.: #67770]	Sample type/isolated from	Wound

[Ref.: #116609]	Sample type/isolated from	Human, Wound
[Ref.: #116609]	Country	United States of America
[Ref.: #116609]	Country ISO 3 Code	USA
[Ref.: #116609]	Continent	North America
* marker position based on {}

Isolation sources categories

#Host Body-Site

#Other

#Wound

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence LC420068 (>99% sequence identity) for Staphylococcus from Microbeatlas

Aquatic Samples	991
Soil Samples	353
Animal Samples	21663
Plant Samples	192
Total Samples	23199

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #1123]	Pathogenicity (human)	yes
[Ref.: #1123]	Pathogenicity (animal)	yes
[Ref.: #1123]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #116609]	Biosafety level	2	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Staphylococcus aureus JCM 2874 gene for 16S ribosomal RNA, partial sequence	LC420068	1473	GenBank ENA	1280 tax ID
[Ref.: #124043]	Staphylococcus aureus NBRC 15035 gene for 16S rRNA, partial sequence.	AB680755	1477	GenBank ENA	1280 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Staphylococcus aureus ATCC 29213	GCA_022870465	complete	GenBank ENA	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus ATCC 29213	GCA_001267715	contig	GenBank ENA	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain NCTC12973	1280.18110	wgs	PATRIC	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain SA29213-A	1280.26265	wgs	PATRIC	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus strain SA29213-B	1280.26266	wgs	PATRIC	1280 tax ID	*
[Ref.: #66792]	Staphylococcus aureus subsp. aureus strain ATCC 29213	46170.287	wgs	PATRIC	1280 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Streptomyces sioyaensis strain B-5408 PATRIC: 67364.6
[Ref.: #69481]	spore-forming	spore-formingⓘ	yes	100	no

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Staphylococcus aureus ATCC 29213 NCBI: GCA_022832775.1
[Ref.: #69480]	gram-positive	gram-positiveⓘ	yes	85.238	no
[Ref.: #69480]	anaerobic	anaerobicⓘ	no	99.36	yes
[Ref.: #69480]	aerobic	aerobicⓘ	yes	53.102	yes
[Ref.: #69480]	spore-forming	spore-formingⓘ	no	71.166	no
[Ref.: #69480]	thermophilic	thermophileⓘ	no	94.358	yes
[Ref.: #69480]	flagellated	motile2+ⓘ	no	79.442	no

Availability in culture collections External links

[Ref.: #1123]

Culture collection no.

CCUG 15915, DSM 2569, ATCC 29213, WDCM 00131, JCM 2874, CCM 4223, CECT 794, CIP 103429, IFO 15035, LMG 10147, NBIMCC 3999, NBRC 15035, NCTC 12973

[Ref.: #83592]

SI-ID 4996

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Pathogenicity	Thymol Reduces agr-Mediated Virulence Factor Phenol-Soluble Modulin Production in Staphylococcus aureus.	Lade H, Chung SH, Lee Y, Kumbhar BV, Joo HS, Kim YG, Yang YH, Kim JS	Biomed Res Int	10.1155/2022/8221622	2022	*
Pathogenicity	In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives.	Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S	Molecules	10.3390/molecules27092722	2022	*
Biotechnology	Effects of citronellal on growth and enterotoxins production in Staphylococcus aureus ATCC 29213.	Zhang M, Li H, Agyekumwaa AK, Yu Y, Xiao X	Toxicon	10.1016/j.toxicon.2022.04.016	2022	*
Pathogenicity	Tagetes lucida Cav. essential oil and the mixture of its main compounds are antibacterial and modulate antibiotic resistance in multi-resistant pathogenic bacteria.	Torres-Martinez R, Moreno-Leon A, Garcia-Rodriguez YM, Hernandez-Delgado T, Delgado-Lamas G, Espinosa-Garcia FJ	Lett Appl Microbiol	10.1111/lam.13721	2022	*
Phylogeny	Isolation and Characterization of Halophilic Kocuria salsicia Strains from Cheese Brine.	Youn HY, Seo KH	Food Sci Anim Resour	10.5851/kosfa.2022.e1	2022	*
Pathogenicity	Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study.	Unlu O, Bingul ES, Kesici S, Demirci M	ADMET DMPK	10.5599/admet.1042	2021	*
Pathogenicity	Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections.	Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N	Nanomaterials (Basel)	10.3390/nano12050856	2022	*
Pathogenicity	Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of New Thiosemicarbazide-Triazole Hybrid Derivatives of (S)-Naproxen.	Han MI, Ince U, Gunduz MG, Kucukguzel SG	Chem Biodivers	10.1002/cbdv.202100900	2022	*
Pathogenicity	Antibacterial activity and mechanism of essential oils in combination with medium-chain fatty acids against predominant bovine mastitis pathogens.	Rani S, Verma S, Singh H, Ram C	Lett Appl Microbiol	10.1111/lam.13675	2022	*
Pathogenicity	Contribution to the Evaluation of Physicochemical Properties, Total Phenolic Content, Antioxidant Potential, and Antimicrobial Activity of Vinegar Commercialized in Morocco.	Kara M, Assouguem A, Fadili ME, Benmessaoud S, Alshawwa SZ, Kamaly OA, Saghrouchni H, Zerhouni AR, Bahhou J	Molecules	10.3390/molecules27030770	2022	*
Pathogenicity	Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.	Gaillard T, Dupieux-Chabert C, Butin M, Dumitrescu O, Naceur O, Bouveyron C, Martra A, Bes M, Tristan A, Vandenesch F, Lina G, Laurent F, Rasigade JP	J Antimicrob Chemother	10.1093/jac/dkab488	2022	*
Pathogenicity	Comparative Study of Antimicrobial, Anti-Inflammatory, and Antioxidant Activities of Different Parts from Pterocarpus Santalinoides l'Her. Ex. DC (Fabaceae).	Ayena AC, Anani K, Dosseh K, Agbonon A, Gbeassor M	Evid Based Complement Alternat Med	10.1155/2021/8938534	2021	*
Pathogenicity	Towards Property Profiling: SYNTHESIS and SAR Probing of New Tetracyclic Diazaphenothiazine Analogues.	Empel A, Bak A, Kozik V, Latocha M, Cizek A, Jampilek J, Suwinska K, Sochanik A, Zieba A	Int J Mol Sci	10.3390/ijms222312826	2021	*
Pathogenicity	A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking.	Zhang Z, Zhang ZS, Wang X, Xi GL, Jin Z, Tang YZ	J Enzyme Inhib Med Chem	10.1080/14756366.2021.1977931	2021	*
Enzymology	Penicisteckins A-F, Isochroman-Derived Atropisomeric Dimers from Penicillium steckii HNNU-5B18.	Wu XZ, Huang WJ, Liu W, Mandi A, Zhang Q, Zhang L, Zhang W, Kurtan T, Yuan CS, Zhang C	J Nat Prod	10.1021/acs.jnatprod.1c00787	2021	*
Pathogenicity	Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics.	Zhang D, Cao Y, Wang K, Shi Z, Wang R, Meng Q, Bi Y	Molecules	10.3390/molecules26195969	2021	*
Pathogenicity	Chalcogenide nanoparticles and organic photosensitizers for synergetic antimicrobial photodynamic therapy.	Garin C, Alejo T, Perez-Laguna V, Prieto M, Mendoza G, Arruebo M, Sebastian V, Rezusta A	J Mater Chem B	10.1039/d1tb00972a	2021	*
Pathogenicity	Aloe-Emodin-Mediated Photodynamic Therapy Attenuates Sepsis-Associated Toxins in Selected Gram-Positive Bacteria In Vitro.	Otieno W, Liu C, Ji Y	J Microbiol Biotechnol	10.4014/jmb.2105.05024	2021	*
Biotechnology	Antimicrobial Effects of Novel H2O2-Ag+ Complex on Membrane Damage to Staphylococcus aureus, Escherichia coli O157:H7, and Salmonella Typhimurium.	Han B, Han X, Ren M, You Y, Zhan J, Huang W	J Food Prot	10.4315/JFP-21-087	2022	*
Pathogenicity	Rational Design of Dipicolylamine-Containing Carbazole Amphiphiles Combined with Zn(2+) as Potent Broad-Spectrum Antibacterial Agents with a Membrane-Disruptive Mechanism.	Liu J, Li H, Li H, Fang S, Shi J, Chen Y, Zhong R, Liu S, Lin S	J Med Chem	10.1021/acs.jmedchem.1c00858	2021	*
Pathogenicity	Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.	Li B, Zhang Z, Zhang JF, Liu J, Zuo XY, Chen F, Zhang GY, Fang HQ, Jin Z, Tang YZ	Eur J Med Chem	10.1016/j.ejmech.2021.113624	2021	*
Phylogeny	Study of the impact of cultivation conditions and peg surface modification on the in vitro biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis in a system analogous to the Calgary biofilm device.	Diepoltova A, Konecna K, Jandourek O, Nachtigal P	J Med Microbiol	10.1099/jmm.0.001371	2021	*
Pathogenicity	Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.	Huang SY, Wang X, Shen DY, Chen F, Zhang GY, Zhang Z, Li K, Jin Z, Du D, Tang YZ	Bioorg Med Chem	10.1016/j.bmc.2021.116138	2021	*
Pathogenicity	Effect of sub-lethal doses of nisin on Staphylococcus aureus toxin production and biofilm formation.	Shivaee A, Rajabi S, Farahani HE, Imani Fooladi AA	Toxicon	10.1016/j.toxicon.2021.03.018	2021	*
Pathogenicity	Composition of Essential Oils from Roots and Aerial Parts of Carpesium cernuum and Their Antibacterial and Cytotoxic Activities.	Wajs-Bonikowska A, Malarz J, Szoka L, Kwiatkowski P, Stojakowska A	Molecules	10.3390/molecules26071883	2021	*
Enzymology	Moringa oleifera leaves: could solvent and extraction method affect phenolic composition and bioactivities?	Bennour N, Mighri H, Bouhamda T, Mabrouk M, Apohan E, Yesilada O, Kucukbay H, Akrout A	Prep Biochem Biotechnol	10.1080/10826068.2021.1891550	2021	*
Pathogenicity	Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma.	Gunduz MK, Bolat M, Kaymak G, Berikten D, Kose DA	Biol Trace Elem Res	10.1007/s12011-021-02647-9	2021	*
Pathogenicity	Development and characterization of lyophilized cefpodoxime proxetil-Pluronic((R)) F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity.	Yurtdas-Kirimlioglu G	Pharm Dev Technol	10.1080/10837450.2021.1889584	2021	*
Pathogenicity	Ultrastructural changes in methicillin-resistant Staphylococcus aureus (MRSA) induced by a novel cyclic peptide ASP-1 from Bacillus subtilis: A scanning electron microscopy (SEM) study.	Deshmukh R, Chalasani AG, Chattopadhyay D, Roy U	Rev Argent Microbiol	10.1016/j.ram.2020.11.006	2021	*
Enzymology	Antibacterial Prenylated p-Hydroxybenzoic Acid Derivatives from Oberonia myosurus and Identification of Putative Prenyltransferases.	Ren FC, Liu L, Lv YF, Bai X, Kang QJ, Hu XJ, Zhuang HD, Yang L, Hu JM, Zhou J	J Nat Prod	10.1021/acs.jnatprod.0c01101	2021	*
Metabolism	Extracellular myco-synthesis of nano-silver using the fermentable yeasts Pichia kudriavzeviiHA-NY2 and Saccharomyces uvarumHA-NY3, and their effective biomedical applications.	Ammar HA, El Aty AAA, El Awdan SA	Bioprocess Biosyst Eng	10.1007/s00449-020-02494-3	2021	*
Pathogenicity	The sponges Hymeniacidon perlevis and Halichondria panicea are reservoirs of antibiotic-producing bacteria against multi-drug resistant Staphylococcus aureus.	Rodriguez Jimenez A, Dechamps E, Giaux A, Goetghebuer L, Bauwens M, Willenz P, Flahaut S, Laport MS, George IF	J Appl Microbiol	10.1111/jam.14999	2021	*
Pathogenicity	Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment.	Ramzi A, Oumokhtar B, Ez Zoubi Y, Filali Mouatassem T, Benboubker M, El Ouali Lalami A	Biomed Res Int	10.1155/2020/6509740	2020	*
Metabolism	An in vitro selective inhibitory effect of silver(i) aminoacidates against bacteria and intestinal cell lines and elucidation of the mechanism of action by means of DNA binding properties, DNA cleavage and cell cycle arrest.	Rendosova M, Gyepes R, Maruscakova IC, Mudronova D, Sabolova D, Kello M, Vilkova M, Almasi M, Huntosova V, Zemek O, Vargova Z	Dalton Trans	10.1039/d0dt03332d	2020	*
Enzymology	Structurally diverse polyketides and phenylspirodrimanes from the soft coral-associated fungus Stachybotrys chartarum SCSIO41201.	Yang B, Long J, Pang X, Lin X, Liao S, Wang J, Zhou X, Li Y, Liu Y	J Antibiot (Tokyo)	10.1038/s41429-020-00386-y	2020	*
Pathogenicity	Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka.	Green KJ, Dods K, Hammer KA	PLoS One	10.1371/journal.pone.0243246	2020	*
Pathogenicity	Enhancing Drug Efficacy against Mastitis Pathogens-An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis.	Rajamanickam K, Yang J, Chidambaram SB, Sakharkar MK	Animals (Basel)	10.3390/ani10112117	2020	*
Pathogenicity	Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.	Malasala S, Ahmad MN, Akunuri R, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S	Eur J Med Chem	10.1016/j.ejmech.2020.112996	2020	*
Pathogenicity	Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.	Zhang GY, Zhang Z, Li K, Liu J, Li B, Jin Z, Liu YH, Tang YZ	Bioorg Chem	10.1016/j.bioorg.2020.104398	2020	*
Pathogenicity	Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.	Cavalluzzi MM, Budriesi R, De Salvia MA, Quintieri L, Piarulli M, Milani G, Gualdani R, Micucci M, Corazza I, Rosato A, Viale M, Caputo L, Franchini C, Lentini G	Pharmacol Rep	10.1007/s43440-020-00167-2	2020	*
Biotechnology	Antibacterial effects of hydrogen peroxide and caprylic acid on selected foodborne bacteria.	Vyrostkova J, Pipova M, Semjon B, Jevinova P, Regecova I, Malova J	Pol J Vet Sci	10.24425/pjvs.2020.134689	2020	*
Biotechnology	Production of 3-desmethyl protostreptovaricin I from the genetically engineered Streptomyces spectabilis CCTCC M2017417.	Liu Y, Cui X, Li Z, Chen X, Zeng G, Sun Y	J Asian Nat Prod Res	10.1080/10286020.2020.1816976	2020	*
Pathogenicity	Type I collagen hydrogels as a delivery matrix for royal jelly derived extracellular vesicles.	Ramirez OJ, Alvarez S, Contreras-Kallens P, Barrera NP, Aguayo S, Schuh CMAP	Drug Deliv	10.1080/10717544.2020.1818880	2020	*
Enzymology	Development of Highly Potent Carbazole Amphiphiles as Membrane-Targeting Antimicrobials for Treating Gram-Positive Bacterial Infections.	Lin S, Liu J, Li H, Liu Y, Chen Y, Luo J, Liu S	J Med Chem	10.1021/acs.jmedchem.0c00433	2020	*
Enzymology	Azacoccones F-H, new flavipin-derived alkaloids from an endophytic fungus Epicoccum nigrum MK214079.	Harwoko H, Lee J, Hartmann R, Mandi A, Kurtan T, Muller WEG, Feldbrugge M, Kalscheuer R, Ancheeva E, Daletos G, Frank M, Liu Z, Proksch P	Fitoterapia	10.1016/j.fitote.2020.104698	2020	*
Pathogenicity	Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agents.	Amann LF, Vicente ER, Rathke M, Broeker A, Riedner M, Wicha SG	Eur J Clin Microbiol Infect Dis	10.1007/s10096-020-03970-0	2020	*
Phylogeny	In Vitro Antimicrobial and Antiproliferative Activities of the Root Bark Extract and Isolated Chemical Constituents of Zanthoxylum paracanthum Kokwaro (Rutaceae).	Kaigongi MM, Lukhoba CW, Yaouba S, Makunga NP, Githiomi J, Yenesew A	Plants (Basel)	10.3390/plants9070920	2020	*
Phylogeny	Molecular Mechanisms and Epidemiology of Fosfomycin Resistance in Staphylococcus aureus Isolated From Patients at a Teaching Hospital in China.	Xu W, Chen T, Wang H, Zeng W, Wu Q, Yu K, Xu Y, Zhang X, Zhou T	Front Microbiol	10.3389/fmicb.2020.01290	2020	*
Pathogenicity	Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols.	Pospisilova S, Malik I, Curillova J, Michnova H, Cerna L, Padrtova T, Hosek J, Pecher D, Cizek A, Jampilek J	Bioorg Chem	10.1016/j.bioorg.2020.104060	2020	*
Pathogenicity	Design, synthesis, and evaluation of amphiphilic sofalcone derivatives as potent Gram-positive antibacterial agents.	Lin S, Chen Y, Li H, Liu J, Liu S	Eur J Med Chem	10.1016/j.ejmech.2020.112596	2020	*
Pathogenicity	Synthesis of Iron(II)-N-Heterocyclic Carbene Complexes: Paving the Way for a New Class of Antibiotics.	Vinagreiro CS, Lopes R, Royo B, Da Silva GJ, Pereira MM	Molecules	10.3390/molecules25122917	2020	*
Pathogenicity	Activity-directed expansion of a series of antibacterial agents.	Leggott A, Clarke JE, Chow S, Warriner SL, O'Neill AJ, Nelson A	Chem Commun (Camb)	10.1039/d0cc02361b	2020	*
Metabolism	Biogenic iron-silver nanoparticles inhibit bacterial biofilm formation due to Ag(+) release as determined by a novel phycoerythrin-based assay.	Cusimano MG, Ardizzone F, Nasillo G, Gallo M, Sfriso A, Martino-Chillura D, Schillaci D, Baldi F, Gallo G	Appl Microbiol Biotechnol	10.1007/s00253-020-10686-w	2020	*
Pathogenicity	Antimicrobial and Anti-Inflammatory Activity of Some Lathyrus L. (Fabaceae) Species Growing in Turkey.	Heydari H, Saltan Iscan G, Eryilmaz M, Bahadir Acikara O, Yilmaz Sarialtin S, Tekin M, Coban T	Turk J Pharm Sci	10.4274/tjps.galenos.2018.86719	2019	*
Pathogenicity	Chemical composition, antimicrobial and cytotoxic activities of essential oils from Schinus polygamus (Cav.) cabrera leaf and bark grown in Egypt.	El-Nashar HAS, Mostafa NM, El-Badry MA, Eldahshan OA, Singab ANB	Nat Prod Res	10.1080/14786419.2020.1765343	2020	*
Metabolism	A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4.	Zhan N, Wang T, Zhang L, Shan A	Braz J Microbiol	10.1007/s42770-020-00291-4	2020	*
Pathogenicity	Development and Characterization of Polymeric Peptides for Antibody Tagging of Bacterial Targets.	Climacosa FMM, King RAN, Santos BMM, Caoili SEC	Protein Pept Lett	10.2174/0929866527666200427212940	2020	*
Pathogenicity	High Fluence Increases the Antibacterial Efficacy of PACK Cross-Linking.	Kling S, Hufschmid FS, Torres-Netto EA, Randleman JB, Willcox M, Zbinden R, Hafezi F	Cornea	10.1097/ICO.0000000000002335	2020	*
Pathogenicity	Optimization of activity localization of quinoline derivatives: Design, synthesis, and dual evaluation of biological activity for potential antitumor and antibacterial agents.	Jin G, Li Z, Xiao F, Qi X, Sun X	Bioorg Chem	10.1016/j.bioorg.2020.103837	2020	*
Enzymology	Antifungal polyketide derivatives from the endophytic fungus Aplosporella javeedii.	Gao Y, Wang L, Kalscheuer R, Liu Z, Proksch P	Bioorg Med Chem	10.1016/j.bmc.2020.115456	2020	*
Enzymology	Antimicrobial activity of endophytic fungi from the medicinal plants Mammea americana (Calophyllaceae) and Moringa oleifera (Moringaceae)	Mosquera WG, Criado LY, Guerra BE	Biomedica	10.7705/biomedica.4644	2020	*
Pathogenicity	Identification of ica-dependent biofilm production by Staphylococcus aureus clinical isolates and antibiofilm effects of ascorbic acid against biofilm production.	Kirmusaoglu S, Kasikci H	J Clin Pathol	10.1136/jclinpath-2019-206280	2020	*
Pathogenicity	Chemical composition and antibacterial activity of essential oils against pathogens often related to cattle endometritis.	Braga Paiano R, Bonilla J, Moro de Sousa RL, Micke Moreno A, Sampaio Baruselli P	J Infect Dev Ctries	10.3855/jidc.12076	2020	*
Pathogenicity	Cladosins L-O, new hybrid polyketides from the endophytic fungus Cladosporium sphaerospermum WBS017.	Pan F, El-Kashef DH, Kalscheuer R, Muller WEG, Lee J, Feldbrugge M, Mandi A, Kurtan T, Liu Z, Wu W, Proksch P	Eur J Med Chem	10.1016/j.ejmech.2020.112159	2020	*
Metabolism	Synthesis of naphthalimide derivatives with potential anticancer activity, their comparative ds- and G-quadruplex-DNA binding studies and related biological activities.	Yildiz U, Kandemir I, Comert F, Akkoc S, Coban B	Mol Biol Rep	10.1007/s11033-019-05239-y	2020	*
Pathogenicity	Design, Synthesis, and Dual Evaluation of Quinoline and Quinolinium Iodide Salt Derivatives as Potential Anticancer and Antibacterial Agents.	Jin G, Xiao F, Li Z, Qi X, Zhao L, Sun X	ChemMedChem	10.1002/cmdc.202000002	2020	*
Pathogenicity	Inhibition of Drug Resistance of Staphylococcus aureus by Efflux Pump Inhibitor and Autolysis Inducer to Strengthen the Antibacterial Activity of beta-lactam Drugs.	Luan W, Liu X, Wang X, An Y, Wang Y, Wang C, Shen K, Xu H, Li S, Liu M, Yu LU	Pol J Microbiol	10.33073/pjm-2019-047	2019	*
Metabolism	Green synthesis of ZnO nanoparticles with Veronica multifida and their antibiofilm activity.	Dogan SS, Kocabas A	Hum Exp Toxicol	10.1177/0960327119888270	2019	*
Pathogenicity	In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.	Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB	Vet Dermatol	10.1111/vde.12803	2019	*
Pathogenicity	Vancomycin-loaded oxidized hyaluronic acid and adipic acid dihydrazide hydrogel: Bio-compatibility, drug release, antimicrobial activity, and biofilm model.	Liao CH, Chen CS, Chen YC, Jiang NE, Farn CJ, Shen YS, Hsu ML, Chang CH	J Microbiol Immunol Infect	10.1016/j.jmii.2019.08.008	2019	*
Pathogenicity	Recent Patents on Impact of Lipopeptide on the Biofilm Formation onto Titanium and Stainless Steel Surfaces.	Pires MEE, Parreira AG, Silva TNL, Colares HC, da Silva JA, de Magalhaes JT, Galdino AS, Goncalves DB, Granjeiro JM, Granjeiro PA	Recent Pat Biotechnol	10.2174/1872208313666190822150323	2020	*
Metabolism	Impact of co-cultivation with Enterococcus faecalis over growth, enterotoxin production and gene expression of Staphylococcus aureus in broth and fresh cheeses.	Nogueira Vicosa G, Vieira Botelho C, Botta C, Bertolino M, Fernandes de Carvalho A, Nero LA, Cocolin L	Int J Food Microbiol	10.1016/j.ijfoodmicro.2019.108291	2019	*
Pathogenicity	Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.	Jin Z, Wang L, Gao H, Zhou YH, Liu YH, Tang YZ	Eur J Med Chem	10.1016/j.ejmech.2019.111594	2019	*
Pathogenicity	Bacterial inhibition efficiency of prilocaine and bupivacaine.	Kesici S, Demirci M, Kesici U	Int Wound J	10.1111/iwj.13180	2019	*
Pathogenicity	Antibacterial effects of lidocaine and adrenaline.	Kesici S, Demirci M, Kesici U	Int Wound J	10.1111/iwj.13182	2019	*
Pathogenicity	Prenylated flavonoid-enriched fraction from Maclura tinctoria shows biological activity against Staphylococcus aureus and protects Galleria mellonella larvae from bacterial infection.	das Chagas Almeida A, Azevedo Rodrigues L, Dos Santos Paulino G, Pereira Aguilar A, Andrade Almeida A, Olavo Ferreira S, Brandao GC, Viana Leite JP, de Oliveira Barros Ribon A	BMC Complement Altern Med	10.1186/s12906-019-2600-y	2019	*
Pathogenicity	In vitro evaluation of methicillin-resistant and methicillin-sensitive Staphylococcus aureus susceptibility to Saudi honeys.	Hussain MB, Kamel YM, Ullah Z, Jiman-Fatani AAM, Ahmad AS	BMC Complement Altern Med	10.1186/s12906-019-2603-8	2019	*
Cultivation	Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.	Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP	J Clin Microbiol	10.1128/JCM.00567-19	2019	*
Pathogenicity	Investigation of silver nanoparticles on titanium surface created by ion implantation technology.	Lampe I, Beke D, Biri S, Csarnovics I, Csik A, Dombradi Z, Hajdu P, Hegedus V, Racz R, Varga I, Hegedus C	Int J Nanomedicine	10.2147/IJN.S197782	2019	*
Pathogenicity	The Antibiofilm Effect of a Medical Device Containing TIAB on Microorganisms Associated with Surgical Site Infection.	Puca V, Traini T, Guarnieri S, Carradori S, Sisto F, Macchione N, Muraro R, Mincione G, Grande R	Molecules	10.3390/molecules24122280	2019	*
Pathogenicity	Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models.	Su M, Qiu L, Deng Y, Ruiz CH, Rudolf JD, Dong LB, Feng X, Cameron MD, Shen B, Duan Y, Huang Y	Mol Pharm	10.1021/acs.molpharmaceut.9b00293	2019	*
Enzymology	Pharmacokinetics and pharmacodynamics of intramammary cefquinome in lactating goats with and without experimentally induced Staphylococcus aureus mastitis.	El Badawy SA, Amer AMM, Kamel GM, Eldeib KM, Constable PD	J Vet Pharmacol Ther	10.1111/jvp.12790	2019	*
Metabolism	Pharmacokinetic profile of amoxicillin and its glucuronide-like metabolite when administered subcutaneously to koalas (Phascolarctos cinereus).	Kimble B, Vogelnest L, Gharibi S, Izes AM, Govendir M	J Vet Pharmacol Ther	10.1111/jvp.12767	2019	*
Phylogeny	Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions.	Diaz-Roa A, Espinoza-Culupu A, Torres-Garcia O, Borges MM, Avino IN, Alves FL, Miranda A, Patarroyo MA, da Silva PI Jr, Bello FJ	Molecules	10.3390/molecules24112077	2019	*
Pathogenicity	Antimicrobial effects of local anaesthetics.	Kesici U, Demirci M, Kesici S	Int Wound J	10.1111/iwj.13153	2019	*
Pathogenicity	Fabrication and physicochemical and antibacterial properties of ethyl cellulose-structured cinnamon oil oleogel: relation between ethyl cellulose viscosity and oleogel performance.	Zhang K, Wang W, Wang X, Cheng S, Zhou J, Wu Z, Li Y	J Sci Food Agric	10.1002/jsfa.9636	2019	*
Pathogenicity	Antibiofilm Nitric Oxide-Releasing Polydopamine Coatings.	Sadrearhami Z, Shafiee FN, Ho KKK, Kumar N, Krasowska M, Blencowe A, Wong EHH, Boyer C	ACS Appl Mater Interfaces	10.1021/acsami.8b16853	2019	*
Pathogenicity	Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics.	Nussbaumer-Proll AK, Knotzer S, Eberl S, Reiter B, Stimpfl T, Jager W, Poschner S, Zeitlinger M	Eur J Clin Microbiol Infect Dis	10.1007/s10096-018-03452-4	2019	*
Pathogenicity	Antibacterial activity of Morinda citrifolia Linneo seeds against Methicillin-Resistant Staphylococcus spp.	De La Cruz-Sanchez NG, Gomez-Rivera A, Alvarez-Fitz P, Ventura-Zapata E, Perez-Garcia MD, Aviles-Flores M, Gutierrez-Roman AS, Gonzalez-Cortazar M	Microb Pathog	10.1016/j.micpath.2019.01.030	2019	*
Pathogenicity	Antimicrobial effect of novel hydrogel matrix based on natural polysaccharide Sterculia urens.	Lipovy B, Holoubek J, Vacek L, Ruzicka F, Nedomova E, Postulkova H, Vojtova L	Epidemiol Mikrobiol Imunol	107027		*
Enzymology	Staphylococcus aureus biofilm organization modulated by YycFG two-component regulatory pathway.	Wu S, Huang F, Zhang H, Lei L	J Orthop Surg Res	10.1186/s13018-018-1055-z	2019	*
Metabolism	Novel linear lipopeptide paenipeptin C' binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane.	Moon SH, Huang E	BMC Microbiol	10.1186/s12866-018-1381-7	2019	*
Enzymology	Two new aromatic polyketides from a deep-sea fungus Penicillium sp. SCSIO 06720.	Guo C, Lin XP, Liao SR, Yang B, Zhou XF, Yang XW, Tian XP, Wang JF, Liu YH	Nat Prod Res	10.1080/14786419.2018.1553880	2019	*
Pathogenicity	Chemical composition and antimicrobial activity of essential oil of Helichrysum italicum (Roth) G. Don fil. (Asteraceae) from Montenegro.	Oliva A, Garzoli S, Sabatino M, Tadic V, Costantini S, Ragno R, Bozovic M	Nat Prod Res	10.1080/14786419.2018.1538218	2019	*
Pathogenicity	Transcriptome analysis of silver nanoparticles treated Staphylococcus aureus reveals potential targets for biofilm inhibition.	Singh N, Rajwade J, Paknikar KM	Colloids Surf B Biointerfaces	10.1016/j.colsurfb.2018.12.032	2018	*
Phylogeny	Mollicellins O(-)R, Four New Depsidones Isolated from the Endophytic Fungus Chaetomium sp. Eef-10.	Ouyang J, Mao Z, Guo H, Xie Y, Cui Z, Sun J, Wu H, Wen X, Wang J, Shan T	Molecules	10.3390/molecules23123218	2018	*
Pathogenicity	Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box.	Bhandari V, Chakraborty S, Brahma U, Sharma P	Front Cell Infect Microbiol	10.3389/fcimb.2018.00365	2018	*
Enzymology	Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate.	Xiao J, Gill C, Liang L, Liu J, Wu J, Feng HP, Flanagan S, Tan C, Flattery A	Antimicrob Agents Chemother	10.1128/AAC.00822-18	2018	*
Pathogenicity	Impact of different pathophysiological conditions on antimicrobial activity of glycopeptides in vitro.	Oesterreicher Z, Eberl S, Nussbaumer-Proell A, Peilensteiner T, Zeitlinger M	Clin Microbiol Infect	10.1016/j.cmi.2018.09.004	2018	*
Pathogenicity	Potential bactericidal activity of S. nux-vomica-ZnO nanocomposite against multidrug-resistant bacterial pathogens and wound-healing properties.	Steffy K, Shanthi G, Maroky AS, Selvakumar S	J Trace Elem Med Biol	10.1016/j.jtemb.2018.07.009	2018	*
Metabolism	Antimicrobial and antioxidant activities of phenolic metabolites from flavonoid-producing yeast: Potential as natural food preservatives.	Ng KR, Lyu X, Mark R, Chen WN	Food Chem	10.1016/j.foodchem.2018.07.077	2018	*
Pathogenicity	Biosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate Streptomyces enissocaesilis.	Shaaban M, El-Mahdy AM	IET Nanobiotechnol	10.1049/iet-nbt.2017.0213	2018	*
Biotechnology	Simplistic approach in extracellular synthesis of silver nanoparticles via bioreducing potential of Planococcus plakortidis strain BGCC-51 isolated from dye industry effluent soil.	Chokriwal A, Stephen BJ, Jain D, Singh A	IET Nanobiotechnol	10.1049/iet-nbt.2017.0251	2018	*
Pathogenicity	Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides.	Pospisilova S, Kos J, Michnova H, Kapustikova I, Strharsky T, Oravec M, Moricz AM, Bakonyi J, Kauerova T, Kollar P, Cizek A, Jampilek J	Int J Mol Sci	10.3390/ijms19082318	2018	*
Pathogenicity	Synthesis and characterization of ZnO phytonanocomposite using Strychnos nux-vomica L. (Loganiaceae) and antimicrobial activity against multidrug-resistant bacterial strains from diabetic foot ulcer.	Steffy K, Shanthi G, Maroky AS, Selvakumar S	J Adv Res	10.1016/j.jare.2017.11.001	2017	*
Pathogenicity	Phenotype and RNA-seq-Based transcriptome profiling of Staphylococcus aureus biofilms in response to tea tree oil.	Zhao X, Liu Z, Liu Z, Meng R, Shi C, Chen X, Bu X, Guo N	Microb Pathog	10.1016/j.micpath.2018.07.027	2018	*
Metabolism	Covalent Whey Protein-Rosmarinic Acid Interactions: A Comparison of Alkaline and Enzymatic Modifications on Physicochemical, Antioxidative, and Antibacterial Properties.	Ali M, Keppler JK, Coenye T, Schwarz K	J Food Sci	10.1111/1750-3841.14222	2018	*
Pathogenicity	The antimicrobial spectrum of lysozyme broadened by reductive modification.	Liu J, Wang N, Liu Y, Jin Y, Ma M	Poult Sci	10.3382/ps/pey245	2018	*
Pathogenicity	Inhibitory Effect of 2R,3R-Dihydromyricetin on Biofilm Formation by Staphylococcus aureus.	Wu YP, Bai JR, Grosu E, Zhong K, Liu LJ, Tang MM, Huang YN, Gao H	Foodborne Pathog Dis	10.1089/fpd.2017.2405	2018	*
Metabolism	Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.	Zhang ZS, Huang YZ, Luo J, Jin Z, Liu YH, Tang YZ	Chem Biol Drug Des	10.1111/cbdd.13328	2018	*
Pathogenicity	The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study.	Alonso B, Perez-Granda MJ, Rodriguez-Huerta A, Rodriguez C, Bouza E, Guembe M	J Hosp Infect	10.1016/j.jhin.2018.04.007	2018	*
Metabolism	Staphylococcus aureus undergoes major transcriptional reorganization during growth with Enterococcus faecalis in milk.	Vicosa GN, Botta C, Ferrocino I, Bertolino M, Ventura M, Nero LA, Cocolin L	Food Microbiol	10.1016/j.fm.2018.01.007	2018	*
Pathogenicity	From bugs to drugs: Combating antimicrobial resistance by discovering novel antibiotics.	Abou Fayad A, Itani D, Miari M, Tanelian A, Iweir S, Matar GM	J Infect Dev Ctries	10.3855/jidc.10108	2018	*
Pathogenicity	In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents.	Abuelizz HA, El-Dib RA, Marzouk M, Al-Salahi R	Microb Pathog	10.1016/j.micpath.2018.02.018	2018	*
Enzymology	Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim.	Park JH, Craig W, Marchillo K, Huang DB, Andes DR	Antimicrob Agents Chemother	10.1128/AAC.02550-17	2018	*
Pathogenicity	Anti-endotoxin mechanism of the KW4 peptide in inflammation in RAW 264.7 cells induced by LTA and drug-resistant Staphylococcus aureus 1630.	Lee JK, Park Y	Amino Acids	10.1007/s00726-017-2518-y	2017	*
Pathogenicity	Survivability and fitness cost of heterogeneous vancomycin-intermediate Staphylococcus aureus.	Singh A, Singh S, Singh J, Rahman M, Pathak A, Prasad KN	Indian J Med Microbiol	10.4103/ijmm.IJMM_17_311	2017	*
Stress	Production and mechanical properties of Ti-5Al-2.5Fe-xCu alloys for biomedical applications.	Yamanoglu R, Efendi E, Kolayli F, Uzuner H, Daoud I	Biomed Mater	10.1088/1748-605X/aa957d	2018	*
Pathogenicity	In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing.	Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC	Antimicrob Agents Chemother	10.1128/AAC.01364-17	2017	*
Pathogenicity	Comparative analysis of methicillin-sensitive and resistant Staphylococcus aureus exposed to emodin based on proteomic profiling.	Ji X, Liu X, Peng Y, Zhan R, Xu H, Ge X	Biochem Biophys Res Commun	10.1016/j.bbrc.2017.10.033	2017	*
Pathogenicity	[Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].	Kesli R, Bilgin H, Yilmaz H	Mikrobiyol Bul	10.5578/mb.57362	2017	*
Pathogenicity	Lactococcus lactis as a safe and inexpensive source of bioactive silver composites.	Viorica RP, Pawel P, Kinga M, Michal Z, Katarzyna R, Boguslaw B	Appl Microbiol Biotechnol	10.1007/s00253-017-8443-x	2017	*
Enzymology	Drawbacks of the use of cotrimoxazole in foreign-body infections.	El Haj C, Ribera A, Lloberas N, Tubau F, Ariza J, Murillo O	Enferm Infecc Microbiol Clin (Engl Ed)	10.1016/j.eimc.2017.07.005	2017	*
Phylogeny	Saccharopolyspora hattusasensis sp. nov., isolated from soil.	Veyisoglu A, Saygin H, Tatar D, Bektas KI, Sahin N	Antonie Van Leeuwenhoek	10.1007/s10482-017-0921-8	2017	*
Pathogenicity	Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development.	Xiang H, Cao F, Ming D, Zheng Y, Dong X, Zhong X, Mu D, Li B, Zhong L, Cao J, Wang L, Ma H, Wang T, Wang D	Appl Microbiol Biotechnol	10.1007/s00253-017-8403-5	2017	*
Pathogenicity	Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.	Greimel F, Scheuerer C, Gessner A, Simon M, Kalteis T, Grifka J, Benditz A, Springorum HR, Schaumburger J	Drug Des Devel Ther	10.2147/DDDT.S138888	2017	*
Phylogeny	Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, India.	Shah AM, Shakeel-U-Rehman, Hussain A, Mushtaq S, Rather MA, Shah A, Ahmad Z, Khan IA, Bhat KA, Hassan QP	Microb Pathog	10.1016/j.micpath.2017.06.017	2017	*
Pathogenicity	Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs.	El-Gohary NS, Shaaban MI	Eur J Med Chem	10.1016/j.ejmech.2017.05.064	2017	*
Pathogenicity	Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms.	Giovagnoli S, Pietrella D, Barberini L, Santi C, Carotti A, di Michele A, Ricci M	Int J Pharm	10.1016/j.ijpharm.2017.06.008	2017	*
Pathogenicity	Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures.	Miller N, Brassinne L, Allemeersch D	Acta Clin Belg	10.1080/17843286.2017.1331618	2017	*
Pathogenicity	THERAPEUTIC POTENTIALS OF ETHANOLIC EXTRACT OF LEAVES OF HOLARRHENA FLORIBUNDA (G. DON) DUR. AND SCHINZ (APOCYNACEAE).	Hoekou YP, Tchacondo T, Karou SD, Yerbanga RS, Achoribo E, Da O, Atakpama W, Batawila K	Afr J Tradit Complement Altern Med	10.21010/ajtcam.v14i2.24	2017	*
Pathogenicity	Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr.	Cai C, Zhang Y, Yang D, Hao X, Li S	Nat Prod Res	10.1080/14786419.2017.1317775	2017	*
Pathogenicity	Synthesis and Bioactivity Evaluation of Novel 2-Salicyloylbenzofurans as Antibacterial Agents.	Phan PT, Nguyen TT, Nguyen HT, Le BN, Vu TT, Tran DC, Pham TN	Molecules	10.3390/molecules22050687	2017	*
Pathogenicity	Antibacterial Activity of Desert Truffles from Saudi Arabia Against Staphylococcus aureus and Pseudomonas aeruginosa.	Schillaci D, Cusimano MG, Cascioferro SM, Di Stefano V, Arizza V, Chiaramonte M, Inguglia L, Bawadekji A, Davino S, Gargano ML, Venturella G	Int J Med Mushrooms	10.1615/IntJMedMushrooms.v19.i2.30	2017	*
Pathogenicity	Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).	Aruldass CA, Masalamany SRL, Venil CK, Ahmad WA	Environ Sci Pollut Res Int	10.1007/s11356-017-8855-2	2017	*
Pathogenicity	In situ development and application of natural coatings on non-absorbable sutures to reduce incision site infections.	Masood R, Hussain T, Umar M, Azeemullah, Areeb T, Riaz S	J Wound Care	10.12968/jowc.2017.26.3.115	2017	*
Pathogenicity	Poly(carboxylic acid)-Cyclodextrin/Anionic Porphyrin Finished Fabrics as Photosensitizer Releasers for Antimicrobial Photodynamic Therapy.	Castriciano MA, Zagami R, Casaletto MP, Martel B, Trapani M, Romeo A, Villari V, Sciortino MT, Grasso L, Guglielmino S, Scolaro LM, Mazzaglia A	Biomacromolecules	10.1021/acs.biomac.6b01752	2017	*
Phylogeny	Microbiological analysis, antimicrobial activity, and heavy-metals content of Jordanian Ma'in hot-springs water.	Shakhatreh MAK, Jacob JH, Hussein EI, Masadeh MM, Obeidat SM, Juhmani AF, Abd Al-Razaq MA	J Infect Public Health	10.1016/j.jiph.2017.01.010	2017	*
Metabolism	Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.	Gao ML, Zeng J, Fang X, Luo J, Jin Z, Liu YH, Tang YZ	Eur J Med Chem	10.1016/j.ejmech.2017.01.004	2017	*
Phylogeny	Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil.	Ong KS, Aw YK, Lee LH, Yule CM, Cheow YL, Lee SM	Front Microbiol	10.3389/fmicb.2016.02046	2016	*
Pathogenicity	iTRAQ-based proteome analysis of fluoroquinolone-resistant Staphylococcus aureus.	Thai VC, Lim TK, Le KPU, Lin Q, Nguyen TTH	J Glob Antimicrob Resist	10.1016/j.jgar.2016.11.003	2016	*
Proteome	Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself.	Ambrose PG, VanScoy B, Conde H, McCauley J, Rubino CM, Bhavnani SM	Antimicrob Agents Chemother	10.1128/AAC.01605-16	2016	*
Transcriptome	Comparative virulence studies and transcriptome analysis of Staphylococcus aureus strains isolated from animals.	Iqbal Z, Seleem MN, Hussain HI, Huang L, Hao H, Yuan Z	Sci Rep	10.1038/srep35442	2016	*
Pathogenicity	Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites.	Di Giulio M, Genovese S, Fiorito S, Epifano F, Nostro A, Cellini L	Nat Prod Res	10.1080/14786419.2015.1079908	2015	*
Enzymology	[Bioactive quinolizidine alkaloids from Sophora tonkinensis].	Zhang Y, Hu WZ, Chen XZ, Peng YB, Song LY, Shi YS	Zhongguo Zhong Yao Za Zhi	10.4268/cjcmm20161215	2016	*
Enzymology	In vivo bactericidal efficacy of farnesol on Ti6Al4V implants.	Constantino JA, Delgado-Rastrollo M, Pacha-Olivenza MA, Perez-Giraldo C, Quiles M, Gonzalez-Martin ML, Gallardo-Moreno AM	Rev Esp Cir Ortop Traumatol	10.1016/j.recot.2016.04.004	2016	*
Pathogenicity	[ABILITY OF STAPHYLOCOCCUS OF VARIOUS STRAINS TO CREATE BIOFILMS AND THEIR EFFECT ON HUMAN BODY CELLS].	Kornienko MA, Kopyltsov VN, Shevlyagina NV, Didenko LV, Lyubasovskaya LA, Priputnevich TV, Ilina EN	Mol Gen Mikrobiol Virusol		2016	*
Metabolism	Studies on bioactivity and secondary metabolites of crude extracts of Bidens pilosa L. (Asteraceae): A medicinal plant used in the Transkei region of South Africa.	Njume C, Gqaza BM, Rozani C, Goduka NI	Pak J Pharm Sci		2016	*
Pathogenicity	Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro.	Aldahoun MA, Jaafar MS, Al-Akhras MH, Bououdina M	Artif Cells Nanomed Biotechnol	10.1080/21691401.2016.1178137	2016	*
Pathogenicity	Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis.	Saidykhan L, Abu Bakar MZ, Rukayadi Y, Kura AU, Latifah SY	Int J Nanomedicine	10.2147/IJN.S95885	2016	*
Pathogenicity	Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth.	Kifer D, Muzinic V, Klaric MS	J Antibiot (Tokyo)	10.1038/ja.2016.10	2016	*
Metabolism	Evaluation of Antibacterial Activity and Reactive Species Generation of N-Benzenesulfonyl Derivatives of Heterocycles.	Martinez SR, Miana GE, Albesa I, Mazzieri MR, Becerra MC	Chem Pharm Bull (Tokyo)	10.1248/cpb.c15-00682	2016	*
Pathogenicity	Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.	Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H	Molecules	10.3390/molecules21010062	2016	*
Pathogenicity	Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.	Adahoun MA, Al-Akhras MH, Jaafar MS, Bououdina M	Artif Cells Nanomed Biotechnol	10.3109/21691401.2015.1129628	2016	*
Pathogenicity	Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus.	Meng Y, Hou X, Lei J, Chen M, Cong S, Zhang Y, Ding W, Li G, Li X	Pharm Res	10.1007/s11095-015-1825-9	2015	*
Pathogenicity	Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities.	Li J, Sui YP, Xin JJ, Du XL, Li JT, Huo HR, Ma H, Wang WH, Zhou HY, Zhan HD, Wang ZJ, Li C, Sui F, Li X	Bioorg Med Chem Lett	10.1016/j.bmcl.2015.10.063	2015	*
Pathogenicity	Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing.	Hombach M, Maurer FP, Pfiffner T, Bottger EC, Furrer R	J Clin Microbiol	10.1128/JCM.02351-15	2015	*
Genetics	Draft Genome Sequence of Methicillin-Sensitive Staphylococcus aureus ATCC 29213.	Soni I, Chakrapani H, Chopra S	Genome Announc	10.1128/genomeA.01095-15	2015	*
Pathogenicity	Synthesis of Biscoumarin and Dihydropyran Derivatives and Evaluation of Their Antibacterial Activity.	Li J, Lv CW, Li XJ, Qu D, Hou Z, Jia M, Luo XX, Li X, Li MK	Molecules	10.3390/molecules200917469	2015	*
Pathogenicity	Anti-biofilm activity of ultrashort cinnamic acid peptide derivatives against medical device-related pathogens.	Laverty G, McCloskey AP, Gorman SP, Gilmore BF	J Pept Sci	10.1002/psc.2805	2015	*
Pathogenicity	Potency and penetration of telavancin in staphylococcal biofilms.	Kirker KR, Fisher ST, James GA	Int J Antimicrob Agents	10.1016/j.ijantimicag.2015.05.022	2015	*
Pathogenicity	Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.	Alanazi AM, Abdel-Aziz AA, Shawer TZ, Ayyad RR, Al-Obaid AM, Al-Agamy MH, Maarouf AR, El-Azab AS	J Enzyme Inhib Med Chem	10.3109/14756366.2015.1060482	2015	*
Pathogenicity	Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).	Zadrazilova I, Pospisilova S, Masarikova M, Imramovsky A, Ferriz JM, Vinsova J, Cizek A, Jampilek J	Eur J Pharm Sci	10.1016/j.ejps.2015.06.009	2015	*
Pathogenicity	Synthesis of biscoumarin and dihydropyran derivatives as two novel classes of potential anti-bacterial derivatives.	Li J, Xue XY, Li X, Hou Z, Yang XH, Qu D, Zhou Y, Zhang ZD, Luo XX, Li JT, Li MK	Arch Pharm Res	10.1007/s12272-015-0614-7	2015	*
Pathogenicity	Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus.	Qian M, Tang S, Wu C, Wang Y, He T, Chen T, Xiao X	Int J Med Microbiol	10.1016/j.ijmm.2015.05.001	2015	*
Cultivation	Microbial fuel cell-based diagnostic platform to reveal antibacterial effect of beta-lactam antibiotics.	Schneider G, Czeller M, Rostas V, Kovacs T	Enzyme Microb Technol	10.1016/j.enzmictec.2015.04.004	2015	*
Phylogeny	Development of a novel matrix-assisted laser desorption/ionization time-of-flight mass spectrum (MALDI-TOF-MS)-based typing method to identify meticillin-resistant Staphylococcus aureus clones.	Ueda O, Tanaka S, Nagasawa Z, Hanaki H, Shobuike T, Miyamoto H	J Hosp Infect	10.1016/j.jhin.2014.11.025	2015	*
Phylogeny	Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds.	Torres MJ, Petroselli G, Daz M, Erra-Balsells R, Audisio MC	World J Microbiol Biotechnol	10.1007/s11274-015-1847-9	2015	*
Pathogenicity	Preparation of gentamicin dioctyl sulfosuccinate loaded poly(trimethylene carbonate) matrices intended for the treatment of orthopaedic infections.	ter Boo GA, Grijpma DW, Richards RG, Moriarty TF, Eglin D	Clin Hemorheol Microcirc	10.3233/CH-151935	2015	*
Pathogenicity	Antimicrobial activity of natural products from the flora of Northern Ontario, Canada.	Vandal J, Abou-Zaid MM, Ferroni G, Leduc LG	Pharm Biol	10.3109/13880209.2014.942867	2015	*
Pathogenicity	Anti-virulence potential of eugenyl acetate against pathogenic bacteria of medical importance.	Musthafa KS, Voravuthikunchai SP	Antonie Van Leeuwenhoek	10.1007/s10482-014-0364-4	2015	*
Pathogenicity	Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents.	Li ZP, Li J, Qu D, Hou Z, Yang XH, Zhang ZD, Wang YK, Luo XX, Li MK	J Pharm Pharmacol	10.1111/jphp.12343	2014	*
Pathogenicity	[Influence of Chlorhexidine and Prontosan on Dual Species and Monospecies Biofilms Formed by Staphylococcus aureus and Pseudomonas aeruginosa].	Kuznetsova MV, Encheva YA, Samartsev VA	Antibiot Khimioter		2015	*
Pathogenicity	New biscoumarin derivatives: synthesis, crystal structure, theoretical study and antibacterial activity against Staphylococcus aureus.	Qu D, Li J, Yang XH, Zhang ZD, Luo XX, Li MK, Li X	Molecules	10.3390/molecules191219868	2014	*
Pathogenicity	Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.	Mei Q, Ye Y, Zhu YL, Cheng J, Chang X, Liu YY, Li HR, Li JB	Eur J Clin Microbiol Infect Dis	10.1007/s10096-014-2285-6	2014	*
Enzymology	Antibacterial and anti-biofilm activity of flavonoids and triterpenes isolated from the extracts of Ficus sansibarica Warb. subsp. sansibarica (Moraceae) extracts.	Awolola GV, Koorbanally NA, Chenia H, Shode FO, Baijnath H	Afr J Tradit Complement Altern Med	10.4314/ajtcam.v11i3.19	2014	*
Enzymology	Selection of potential probiotic Enterococcus faecium isolated from Portuguese fermented food.	Barbosa J, Borges S, Teixeira P	Int J Food Microbiol	10.1016/j.ijfoodmicro.2014.09.009	2014	*
Pathogenicity	Synergistic interaction of PMAP-36 and PRW4 with aminoglycoside antibiotics and their antibacterial mechanism.	Wang Z, Zhang L, Wang J, Wei D, Shi B, Shan A	World J Microbiol Biotechnol	10.1007/s11274-014-1739-4	2014	*
Pathogenicity	Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.	Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Denys GA, Goering RV, Shaw KJ	Antimicrob Agents Chemother	10.1128/AAC.03493-14	2014	*
Pathogenicity	Cobalt(II) complexes with the antimicrobial drug enrofloxacin: structure, antimicrobial activity, DNA- and albumin-binding.	Protogeraki C, Andreadou EG, Perdih F, Turel I, Pantazaki AA, Psomas G	Eur J Med Chem	10.1016/j.ejmech.2014.08.043	2014	*
Pathogenicity	Cationic synthetic peptides: assessment of their antimicrobial potency in liquid preserved boar semen.	Speck S, Courtiol A, Junkes C, Dathe M, Muller K, Schulze M	PLoS One	10.1371/journal.pone.0105949	2014	*
Enzymology	Pathogen removal during wastewater treatment by vermifiltration.	Arora S, Rajpal A, Kumar T, Bhargava R, Kazmi AA	Environ Technol	10.1080/09593330.2014.911358	2014	*
Pathogenicity	Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center.	Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Goering RV, Jenkins SG, Shaw KJ	Antimicrob Agents Chemother	10.1128/AAC.03380-14	2014	*
Pathogenicity	Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro.	Zhang C, He X, Gu Y, Zhou H, Cao J, Gao Q	PLoS One	10.1371/journal.pone.0103456	2014	*
Pathogenicity	Influence of physico-chemical material characteristics on staphylococcal biofilm formation--a qualitative and quantitative in vitro analysis of five different calcium phosphate bone grafts.	Clauss M, Furustrand Tafin U, Betrisey B, van Garderen N, Trampuz A, Ilchmann T, Bohner M	Eur Cell Mater	10.22203/ecm.v028a04	2014	*
Pathogenicity	Antimicrobial, insecticidal and phytotoxic activities of Cotinus coggyria Scop. essential oil (Anacardiaceae).	Ulukanli Z, Karaborklu S, Bozok F, Cenet M, Ozturk B, Balcilar M	Nat Prod Res	10.1080/14786419.2014.928879	2014	*
Pathogenicity	Synthesis, antibacterial activities, and theoretical studies of dicoumarols.	Li J, Hou Z, Chen GH, Li F, Zhou Y, Xue XY, Li ZP, Jia M, Zhang ZD, Li MK, Luo XX	Org Biomol Chem	10.1039/c4ob00772g	2014	*
Pathogenicity	Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.	Ross JE, Mendes RE, Jones RN	J Clin Microbiol	10.1128/JCM.01210-14	2014	*
Pathogenicity	Effect of subinhibitory concentrations of chlorogenic acid on reducing the virulence factor production by Staphylococcus aureus.	Li G, Qiao M, Guo Y, Wang X, Xu Y, Xia X	Foodborne Pathog Dis	10.1089/fpd.2013.1731	2014	*
Enzymology	Sensitive and selective near-infrared fluorescent off-on probe and its application to imaging different levels of beta-lactamase in Staphylococcus aureus.	Li L, Li Z, Shi W, Li X, Ma H	Anal Chem	10.1021/ac501288e	2014	*
Pathogenicity	In vitro evaluation of antimicrobial features of sugammadex.	Hanci V, Vural A, Hanci SY, Ali Kiraz H, Omur D, Unver A	Braz J Anesthesiol	10.1016/j.bjane.2013.09.003	2013	*
Pathogenicity	[A study of the single nucleotide polymorphism fragments of the AUR gene metalloprotease strains of Staphylococcus aureus isolated from the skin of patients with atopic dermatitis].	Tuyrin YA, Shamsutdinov AF, Fassahov RS	Mol Gen Mikrobiol Virusol		2014	*
Pathogenicity	Negative-pressure wound therapy enhances local inflammatory responses in acute infected soft-tissue wound.	Liu D, Zhang L, Li T, Wang G, Du H, Hou H, Han L, Tang P	Cell Biochem Biophys	10.1007/s12013-014-9953-0	2014	*
Pathogenicity	Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-mug disk.	Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE	Eur J Clin Microbiol Infect Dis	10.1007/s10096-014-2089-8	2014	*
Enzymology	Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.	Huang Y, Xu Y, Liu S, Wang H, Xu X, Guo Q, Wu B, Gordeev MF, Wang W, Yuan Z, Wang M	Int J Antimicrob Agents	10.1016/j.ijantimicag.2014.02.008	2014	*
Pathogenicity	Extracorporeal shockwave increases the effectiveness of systemic antibiotic treatment in implant-related chronic osteomyelitis: experimental study in a rat model.	Inanmaz ME, Uslu M, Isik C, Kaya E, Tas T, Bayram R	J Orthop Res	10.1002/jor.22604	2014	*
Enzymology	Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.	Wang J, Shan Q, Ding H, Liang C, Zeng Z	Antimicrob Agents Chemother	10.1128/AAC.01666-13	2014	*
Pathogenicity	Synthesis of novel 2-(substituted amino)alkylthiopyrimidin-4(3H)-ones as potential antimicrobial agents.	Attia MI, El-Emam AA, Al-Turkistani AA, Kansoh AL, El-Brollosy NR	Molecules	10.3390/molecules19010279	2013	*
Pathogenicity	Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)ace tyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents.	Suresh N, Nagesh HN, Renuka J, Rajput V, Sharma R, Khan IA, Kondapalli Venkata Gowri CS	Eur J Med Chem	10.1016/j.ejmech.2013.10.055	2013	*
Pathogenicity	Cytotoxic and antibacterial marfuraquinocins from the deep South China Sea-derived Streptomyces niveus SCSIO 3406.	Song Y, Huang H, Chen Y, Ding J, Zhang Y, Sun A, Zhang W, Ju J	J Nat Prod	10.1021/np4006025	2013	*
Pathogenicity	In vitro evaluation of the minimum bactericidal concentrations of different root-end filling materials.	Kocak MM, Kocak S, Oktay EA, Kilic A, Yaman SD	J Contemp Dent Pract	10.5005/jp-journals-10024-1330	2013	*
Pathogenicity	Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study.	Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE	Toxicol Ind Health	10.1177/0748233713498458	2013	*
Pathogenicity	Synthesis, crystal structures, and anti-drug-resistant Staphylococcus aureus activities of novel 4-hydroxycoumarin derivatives.	Li MK, Li J, Liu BH, Zhou Y, Li X, Xue XY, Hou Z, Luo XX	Eur J Pharmacol	10.1016/j.ejphar.2013.09.040	2013	*
Pathogenicity	Probiotic properties of lactobacilli species isolated from children's feces.	Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yasar E	Anaerobe	10.1016/j.anaerobe.2013.09.006	2013	*
Enzymology	Detection and enumeration of Staphylococcus aureus from bovine milk samples by real-time polymerase chain reaction.	Botaro BG, Cortinhas CS, Marco LV, Moreno JFG, Silva LFP, Benites NR, Santos MV	J Dairy Sci	10.3168/jds.2013-6559	2013	*
Enzymology	Bioactive polyketides and alkaloids from Penicillium citrinum, a fungal endophyte isolated from Ocimum tenuiflorum.	Lai D, Brotz-Oesterhelt H, Muller WEG, Wray V, Proksch P	Fitoterapia	10.1016/j.fitote.2013.08.017	2013	*
Pathogenicity	[Effect of cinnamon and lavender oils on FtsZ gene expression in the Staphylococus aureus ATCC 29213].	Herman A, Bochenek J, Herman AP	Prikl Biokhim Mikrobiol		2013	*
Pathogenicity	Comparison of chlorine dioxide and dichloroisocyanurate disinfectants for use in the dental setting.	Patel M, Ebonwu J, Cutler E	SADJ		2012	*
Metabolism	Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides.	Shireen T, Singh M, Das T, Mukhopadhyay K	Antimicrob Agents Chemother	10.1128/AAC.00780-13	2013	*
Enzymology	Antibacterial and cytotoxic new napyradiomycins from the marine-derived Streptomyces sp. SCSIO 10428.	Wu Z, Li S, Li J, Chen Y, Saurav K, Zhang Q, Zhang H, Zhang W, Zhang W, Zhang S, Zhang C	Mar Drugs	10.3390/md11062113	2013	*
Enzymology	New antibacterial germacrene from Verbesina negrensis.	Mora FD, Alpan L, de Tommasi N, McCracken VJ, Nieto M	Planta Med	10.1055/s-0032-1328542	2013	*
Pathogenicity	Antimicrobial activity of newly synthesized methylsulfanyl-triazoloquinazoline derivatives.	Al-Salahi R, Marzouk M, Awad G, Al-Omar M, Ezzeldin E	J Pharm Pharmacol	10.1111/jphp.12039	2013	*
Pathogenicity	Effects of selenium coating of orthopaedic implant surfaces on bacterial adherence and osteoblastic cell growth.	Holinka J, Pilz M, Kubista B, Presterl E, Windhager R	Bone Joint J	10.1302/0301-620X.95B5.31216	2013	*
Pathogenicity	Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.	Rozalski MI, Micota B, Sadowska B, Paszkiewicz M, Wieckowska-Szakiel M, Rozalska B	Postepy Hig Med Dosw (Online)	10.5604/17322693.1046009	2013	*
Pathogenicity	Effects of Zataria multiflora Boiss. essential oil on growth and gene expression of enterotoxins A, C and E in Staphylococcus aureus ATCC 29213.	Azizkhani M, Misaghi A, Basti AA, Gandomi H, Hosseini H	Int J Food Microbiol	10.1016/j.ijfoodmicro.2013.02.020	2013	*
Pathogenicity	Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.	Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA	J Infect Dis	10.1093/infdis/jit138	2013	*
Enzymology	Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model.	Banevicius MA, Kaplan N, Hafkin B, Nicolau DP	J Chemother	10.1179/1973947812Y.0000000061	2013	*
Pathogenicity	Biofilm formation by staphylococci on fresh, fresh-frozen and processed human and bovine bone grafts.	Clauss M, Tafin UF, Bizzini A, Trampuz A, Ilchmann T	Eur Cell Mater	10.22203/ecm.v025a11	2013	*
Enzymology	A rabbit model of right-sided Staphylococcus aureus endocarditis created with echocardiographic guidance.	Wang ML, Zhang Y, Fan M, Guo YJ, Ren WD, Luo EJ	Cardiovasc Ultrasound	10.1186/1476-7120-11-3	2013	*
Pathogenicity	New type of protective hybrid and nanocomposite hybrid coatings containing silver and copper with an excellent antibacterial effect especially against MRSA.	Slamborova I, Zajicova V, Karpiskova J, Exnar P, Stibor I	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2012.08.039	2012	*
Pathogenicity	Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar.	Justesen US, Acar Z, Olsson K, Jensen TG, Kerrn MB, Skov RL, Gahrn-Hansen B	Eur J Clin Microbiol Infect Dis	10.1007/s10096-012-1785-5	2012	*
Pathogenicity	In vitro pharmacodynamics of AZD5206 against Staphylococcus aureus.	Tam VH, Chang KT, Yang Z, Newman J, Hu M	Antimicrob Agents Chemother	10.1128/AAC.01208-12	2012	*
Pathogenicity	Fluostatins I-K from the South China Sea-derived micromonospora rosaria SCSIO N160.	Zhang W, Liu Z, Li S, Lu Y, Chen Y, Zhang H, Zhang G, Zhu Y, Zhang G, Zhang W, Liu J, Zhang C	J Nat Prod	10.1021/np300505y	2012	*
Pathogenicity	Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.	Burian A, Erdogan Z, Jandrisits C, Zeitlinger M	Pharmacology	10.1159/000342423	2012	*
Pathogenicity	Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives.	Guzeldemirci NU, Satana D, Kucukbasmaci O	J Enzyme Inhib Med Chem	10.3109/14756366.2012.700926	2012	*
Pathogenicity	Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.	Ross JE, Sader HS, Ivezic-Schoenfeld Z, Paukner S, Jones RN	J Clin Microbiol	10.1128/JCM.01294-12	2012	*
Pathogenicity	Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.	Zhou Y, Hou Z, Fang C, Xue X, Da F, Wang Y, Bai H, Luo X	Folia Microbiol (Praha)	10.1007/s12223-012-0168-8	2012	*
Pathogenicity	Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus.	Tsuji BT, Brown T, Parasrampuria R, Brazeau DA, Forrest A, Kelchlin PA, Holden PN, Peloquin CA, Hanna D, Bulitta JB	Antimicrob Agents Chemother	10.1128/AAC.05453-11	2012	*
Phenotype	Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.	Bourne CR, Wakeham N, Bunce RA, Nammalwar B, Berlin KD, Barrow WW	J Mol Recognit	10.1002/jmr.2174	2012	*
Pathogenicity	Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C.	Masadeh MM, Mhaidat NM, Alzoubi KH, Al-Azzam SI, Shaweesh AI	Curr Microbiol	10.1007/s00284-012-0094-7	2012	*
Metabolism	[Effects of Staphylococcus aureus supernatant on expression of various cytokines by neutrophils and retinal pigment epithelium cells].	Lou BS, Yuan ZH, Luo YW, Lin XF	Zhonghua Yan Ke Za Zhi		2011	*
Pathogenicity	Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.	Schwameis R, Fille M, Manafi M, Zeitlinger M, Sauermann R	Res Microbiol	10.1016/j.resmic.2011.12.004	2011	*
Pathogenicity	Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression.	Mitchell G, Lafrance M, Boulanger S, Seguin DL, Guay I, Gattuso M, Marsault E, Bouarab K, Malouin F	J Antimicrob Chemother	10.1093/jac/dkr510	2011	*
Pathogenicity	Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model.	Rodriguez CA, Agudelo M, Zuluaga AF, Vesga O	Antimicrob Agents Chemother	10.1128/AAC.05129-11	2011	*
Enzymology	Antimicrobial effect of statins: organic solvents might falsify microbiological testing results.	Matzneller P, Manafi M, Zeitlinger M	Int J Clin Pharmacol Ther	10.5414/cp201581	2011	*
Phylogeny	Lobophorins E and F, new spirotetronate antibiotics from a South China Sea-derived Streptomyces sp. SCSIO 01127.	Niu S, Li S, Chen Y, Tian X, Zhang H, Zhang G, Zhang W, Yang X, Zhang S, Ju J, Zhang C	J Antibiot (Tokyo)	10.1038/ja.2011.78	2011	*
Phylogeny	Pseudonocardians A-C, new diazaanthraquinone derivatives from a deap-sea actinomycete Pseudonocardia sp. SCSIO 01299.	Li S, Tian X, Niu S, Zhang W, Chen Y, Zhang H, Yang X, Zhang W, Li W, Zhang S, Ju J, Zhang C	Mar Drugs	10.3390/md9081428	2011	*
Enzymology	Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.	Alt S, Mitchenall LA, Maxwell A, Heide L	J Antimicrob Chemother	10.1093/jac/dkr247	2011	*
Pathogenicity	Antibiofilm activity of selected plant essential oils and their major components.	Budzynska A, Wieckowska-Szakiel M, Sadowska B, Kalemba D, Rozalska B	Pol J Microbiol		2011	*
Pathogenicity	Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus.	Filocamo A, Bisignano C, D'Arrigo M, Ginestra G, Mandalari G, Galati EM	Lett Appl Microbiol	10.1111/j.1472-765X.2011.03090.x	2011	*
Pathogenicity	Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-beta-boswellic acid from Boswellia serrata.	Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, Taneja SC	BMC Microbiol	10.1186/1471-2180-11-54	2011	*
Pathogenicity	Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design.	Bhagunde P, Singh R, Ledesma KR, Chang KT, Nikolaou M, Tam VH	J Antimicrob Chemother	10.1093/jac/dkr054	2011	*
Pathogenicity	Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate.	Sianglum W, Srimanote P, Wonglumsom W, Kittiniyom K, Voravuthikunchai SP	PLoS One	10.1371/journal.pone.0016628	2011	*
Pathogenicity	Synthesis of egonol derivatives and their antimicrobial activities.	Emirdag-Ozturk S, Karayildirim T, Anil H	Bioorg Med Chem	10.1016/j.bmc.2010.12.044	2010	*
Enzymology	Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic.	Aswani VH, Shukla SK	Clin Med Res	10.3121/cmr.2010.954	2010	*
Pathogenicity	Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates.	Chen CP, Wickstrom E	Bioconjug Chem	10.1021/bc100136e	2010	*
Pathogenicity	Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.	Croes S, Beisser PS, Terporten PH, Neef C, Deurenberg RH, Stobberingh EE	Clin Microbiol Infect	10.1111/j.1469-0691.2010.02956.x	2010	*
Pathogenicity	Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors.	Zander J, Hartenfeller M, Hahnke V, Proschak E, Besier S, Wichelhaus TA, Schneider G	Chemistry	10.1002/chem.201001347	2010	*
Pathogenicity	Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.	Gonzalez R, Albericio F, Cascone O, Iannucci NB	J Pept Sci	10.1002/psc.1258	2010	*
Pathogenicity	MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.	Singh R, Ray P, Das A, Sharma M	Microsc Res Tech	10.1002/jemt.20871	2010	*
Pathogenicity	Antimicrobial properties of prunin, a citric flavanone glucoside, and its prunin 6''-O-lauroyl ester.	Celiz G, Audisio MC, Daz M	J Appl Microbiol	10.1111/j.1365-2672.2010.04773.x	2010	*
Pathogenicity	Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation.	Petek M, Baebler S, Kuzman D, Rotter A, Podlesek Z, Gruden K, Ravnikar M, Urleb U	BMC Microbiol	10.1186/1471-2180-10-159	2010	*
Pathogenicity	Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil.	Bouhdid S, Abrini J, Amensour M, Zhiri A, Espuny MJ, Manresa A	J Appl Microbiol	10.1111/j.1365-2672.2010.04740.x	2010	*
Pathogenicity	Synthesis and antimicrobial activity of novel Ag-N-hetero-cyclic carbene complexes.	Ozdemir I, Ozcan EO, Gunal S, Gurbuz N	Molecules	10.3390/molecules15042499	2010	*
Pathogenicity	Biofilm formation on bone grafts and bone graft substitutes: comparison of different materials by a standard in vitro test and microcalorimetry.	Clauss M, Trampuz A, Borens O, Bohner M, Ilchmann T	Acta Biomater	10.1016/j.actbio.2010.03.011	2010	*
Pathogenicity	[Investigation of antibacterial activity of sertralin].	Coban AY, Tanriverdi Cayci Y, Keles Uludag S, Durupinar B	Mikrobiyol Bul		2009	*
Pathogenicity	Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones.	Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP	Eur J Med Chem	10.1016/j.ejmech.2009.12.030	2009	*
Pathogenicity	In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.	Erdogan H, Can F, Demirbilek M, Timurkaynak F, Arslan H	Environ Monit Assess	10.1007/s10661-009-1293-y	2010	*
Metabolism	Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus.	Paez PL, Becerra MC, Albesa I	FEMS Microbiol Lett	10.1111/j.1574-6968.2009.01867.x	2009	*
Pathogenicity	Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci.	Mueller-Premru M, Zidar N, Spik VC, Krope A, Kikelj D	Chemotherapy	10.1159/000263228	2009	*
Pathogenicity	Relationship between structure and antibacterial activity of lipophilic N-acyldiamines.	de Almeida CG, Garbois GD, Amaral LM, Diniz CC, Le Hyaric M	Biomed Pharmacother	10.1016/j.biopha.2009.09.013	2009	*
Enzymology	Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.	Joukhadar C, Pillai S, Wennersten C, Moellering RC Jr, Eliopoulos GM	Antimicrob Agents Chemother	10.1128/AAC.00348-09	2009	*
Metabolism	Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms.	Di Stefano A, D'Aurizio E, Trubiani O, Grande R, Di Campli E, Di Giulio M, Di Bartolomeo S, Sozio P, Iannitelli A, Nostro A, Cellini L	Microb Biotechnol	10.1111/j.1751-7915.2009.00120.x	2009	*
Pathogenicity	Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms.	Pettit RK, Weber CA, Pettit GR	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-8-28	2009	*
Pathogenicity	Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).	Locke JB, Hilgers M, Shaw KJ	Antimicrob Agents Chemother	10.1128/AAC.00871-09	2009	*
Pathogenicity	Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.	D'Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G	Phytomedicine	10.1016/j.phymed.2009.07.008	2009	*
Cultivation	Comparative evaluation of a rapid MRSA detection assay based on multiplex real-time PCR versus MRSA screening cultures containing egg yolk.	Sumitani Y, Kobayashi Y	J Infect Chemother	10.1007/s10156-009-0685-9	2009	*
Pathogenicity	Ceanothane and lupane type triterpenes from Zizyphus joazeiro - an anti-staphylococcal evaluation.	Leal IC, dos Santos KR, Junior II, Antunes OA, Porzel A, Wessjohann L, Kuster RM	Planta Med	10.1055/s-0029-1185947	2009	*
Pathogenicity	Antimicrobial and antistaphylococcal biofilm activity from the sea urchin Paracentrotus lividus.	Schillaci D, Arizza V, Parrinello N, Di Stefano V, Fanara S, Muccilli V, Cunsolo V, Haagensen JJ, Molin S	J Appl Microbiol	10.1111/j.1365-2672.2009.04394.x	2010	*
Pathogenicity	Synthesis, antibacterial and antifungal activities of novel 1,2,4-triazolium derivatives.	Luo Y, Lu YH, Gan LL, Zhou CH, Wu J, Geng RX, Zhang YY	Arch Pharm (Weinheim)	10.1002/ardp.200800221	2009	*
Pathogenicity	Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens.	Rivardo F, Turner RJ, Allegrone G, Ceri H, Martinotti MG	Appl Microbiol Biotechnol	10.1007/s00253-009-1987-7	2009	*
Pathogenicity	Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil.	Bouhdid S, Abrini J, Zhiri A, Espuny MJ, Manresa A	J Appl Microbiol	10.1111/j.1365-2672.2008.04124.x	2009	*
Pathogenicity	In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils.	Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V	Lett Appl Microbiol	10.1111/j.1472-765X.2008.02469.x	2008	*
Pathogenicity	Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.	Belley A, Neesham-Grenon E, McKay G, Arhin FF, Harris R, Beveridge T, Parr TR Jr, Moeck G	Antimicrob Agents Chemother	10.1128/AAC.00766-08	2008	*
Pathogenicity	Antibacterial effects of three experimental quaternary ammonium salt (QAS) monomers on bacteria associated with oral infections.	Xiao YH, Chen JH, Fang M, Xing XD, Wang H, Wang YJ, Li F	J Oral Sci	10.2334/josnusd.50.323	2008	*
Pathogenicity	Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus.	Genc Y, Ozkanca R, Bekdemir Y	Ann Clin Microbiol Antimicrob	10.1186/1476-0711-7-17	2008	*
Pathogenicity	Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.	Arhin FF, Tomfohrde K, Draghi DC, Aranza M, Parr TR Jr, Sahm DF, Moeck G	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2008.05.009	2008	*
Pathogenicity	Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coil isolates recovered from 80 Ontario swine farms.	Varela NP, Friendship R, Dewey C, Valdivieso A	Can J Vet Res		2008	*
Pathogenicity	Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi.	Ryge TS, Frimodt-Moller N, Hansen PR	Chemotherapy	10.1159/000119707	2008	*
Pathogenicity	Effect of tumor necrosis factor-alpha on intracellular Staphylococcus aureus in vascular endothelial cells.	Park WB, Lee JH, Jeon JH, Lee SJ, Kim SH, Kim NJ, Kim HB, Oh MD, Choe KW	FEMS Immunol Med Microbiol	10.1111/j.1574-695X.2007.00365.x	2008	*
Enzymology	[Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].	Nagasawa Z, Nakashima Y, Oho M, Kusaba K, Manome I, Nagayama A	Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi		2008	*
Pathogenicity	[Influence of doxorubicin on the development of resistance of staphylococci to ceftriaxone].	Shapoval OG	Zh Mikrobiol Epidemiol Immunobiol		2007	*
Pathogenicity	Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus.	Hegde SS, Reyes N, Skinner R, Difuntorum S	J Antimicrob Chemother	10.1093/jac/dkm417	2007	*
Pathogenicity	In vitro ability of Staphylococcus aureus isolates from bacteraemic patients with and without metastatic complications to invade vascular endothelial cells.	Park WB, Kim SH, Kang CI, Cho JH, Bang JW, Park KW, Lee YS, Kim NJ, Oh MD, Kim HB, Won Choe K	J Med Microbiol	10.1099/jmm.0.46765-0	2007	*
Enzymology	[Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension].	Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N	Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi		2006	*
Pathogenicity	Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.	Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB, Goldstein BP	J Clin Microbiol	10.1128/JCM.02411-06	2007	*
Enzymology	Antimicrobial compounds from Eremophila serrulata.	Ndi CP, Semple SJ, Griesser HJ, Pyke SM, Barton MD	Phytochemistry	10.1016/j.phytochem.2007.05.039	2007	*
Enzymology	Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.	Trampuz A, Murphy CK, Rothstein DM, Widmer AF, Landmann R, Zimmerli W	Antimicrob Agents Chemother	10.1128/AAC.00120-07	2007	*
Pathogenicity	Antibiotic susceptibility of potentially probiotic vaginal lactobacilli.	Ocana V, Silva C, Nader-Macias ME	Infect Dis Obstet Gynecol	10.1155/IDOG/2006/18182	2006	*
Pathogenicity	Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F. Muell. (Myoporaceae).	Smith JE, Tucker D, Watson K, Jones GL	J Ethnopharmacol	10.1016/j.jep.2007.03.031	2007	*
Pathogenicity	[Investigation of the efficacy of electrolyzed acid water on the standard strains of some pathogenic microorganisms].	Ileri C, Sezen Y, Dimoglo A	Mikrobiyol Bul		2006	*
Pathogenicity	Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation.	Shaikh AR, Giridhar R, Yadav MR	Int J Pharm	10.1016/j.ijpharm.2006.11.037	2006	*
Pathogenicity	Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.	DeRyke CA, Sutherland C, Zhang B, Nicolau DP, Kuti JL	Antimicrob Agents Chemother	10.1128/AAC.00290-06	2006	*
Pathogenicity	Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.	Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA	Antimicrob Agents Chemother	10.1128/AAC.01165-05	2006	*
Enzymology	Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.	Kalteis T, Beckmann J, Schroder HJ, Handel M, Grifka J, Lehn N, Lerch K	Acta Orthop	10.1080/17453670610046082	2006	*
Pathogenicity	Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM).	Schafer JA, Hovde LB, Rotschafer JC	J Antimicrob Chemother	10.1093/jac/dkl216	2006	*
Pathogenicity	Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests.	Fang M, Chen JH, Xu XL, Yang PH, Hildebrand HF	Int J Antimicrob Agents	10.1016/j.ijantimicag.2006.01.008	2006	*
Pathogenicity	Treatment of implant-associated infections with moxifloxacin: an animal study.	Kalteis T, Beckmann J, Schroder HJ, Schaumburger J, Linde HJ, Lerch K, Lehn N	Int J Antimicrob Agents	10.1016/j.ijantimicag.2005.12.003	2006	*
Enzymology	Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.	Andes D, Craig WA	Antimicrob Agents Chemother	10.1128/AAC.50.4.1376-1383.2006	2006	*
Pathogenicity	Lipids and DNA oxidation in Staphylococcus aureus as a consequence of oxidative stress generated by ciprofloxacin.	Becerra MC, Paez PL, Larovere LE, Albesa I	Mol Cell Biochem	10.1007/s11010-005-9051-0	2006	*
Enzymology	Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.	Andes D, Craig WA	Antimicrob Agents Chemother	10.1128/AAC.50.1.243-249.2006	2006	*
Enzymology	Analysis of the beta-lactamase plasmid of borderline methicillin-susceptible Staphylococcus aureus: focus on bla complex genes and cadmium resistance determinants cadD and cadX.	Massidda O, Mingoia M, Fadda D, Whalen MB, Montanari MP, Varaldo PE	Plasmid	10.1016/j.plasmid.2005.08.001	2005	*
Pathogenicity	Synthesis and evaluation of analgesic/ anti-inflammatory and antimicrobial activities of 3-substituted- 1,2,4-triazole-5-thiones.	Tozkoparan B, Kupeli E, Yesilada E, Isik S, Ozalp M, Ertan M	Arzneimittelforschung	10.1055/s-0031-1296901	2005	*
Pathogenicity	Flow cytometry analysis of the activity of disinfecting agents tested with Staphylococcus aureus and Escherichia coli.	Wozniak-Kosek A, Kawiak J	Pol J Microbiol		2005	*
Pathogenicity	Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.	Liao M, Ruddock PS, Rizvi AS, Hall SH, French FS, Dillon JR	J Antimicrob Chemother	10.1093/jac/dki350	2005	*
Enzymology	The effect of interlaboratory variability on antimicrobial susceptibility determination.	Annis DH, Craig BA	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2005.03.012	2005	*
Pathogenicity	[Impact of Ph-SA on the expression of delta-toxin in Staphylococcus aureus].	Guo L, Zhang J, Tang XY, Qiu XQ	Sichuan Da Xue Xue Bao Yi Xue Ban		2005	*
Pathogenicity	Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.	Liang CH, Romero A, Rabuka D, Sgarbi PW, Marby KA, Duffield J, Yao S, Cheng ML, Ichikawa Y, Sears P, Hu C, Hwang SB, Shue YK, Sucheck SJ	Bioorg Med Chem Lett	10.1016/j.bmcl.2005.02.029	2005	*
Pathogenicity	Identification of novel inhibitors of bacterial translation elongation factors.	Jayasekera MM, Onheiber K, Keith J, Venkatesan H, Santillan A, Stocking EM, Tang L, Miller J, Gomez L, Rhead B, Delcamp T, Huang S, Wolin R, Bobkova EV, Shaw KJ	Antimicrob Agents Chemother	10.1128/AAC.49.1.131-136.2005	2005	*
Pathogenicity	Biofilm susceptibility to metal toxicity.	Harrison JJ, Ceri H, Stremick CA, Turner RJ	Environ Microbiol	10.1111/j.1462-2920.2004.00656.x	2004	*
Metabolism	Light effect and reactive oxygen species in the action of ciprofloxacin on Staphylococcus aureus.	Becerra MC, Sarmiento M, Paez PL, Arguello G, Albesa I	J Photochem Photobiol B	10.1016/j.jphotobiol.2004.06.003	2004	*
Metabolism	Impact of plasma protein binding on antimicrobial activity using time-killing curves.	Zeitlinger MA, Sauermann R, Traunmuller F, Georgopoulos A, Muller M, Joukhadar C	J Antimicrob Chemother	10.1093/jac/dkh443	2004	*
Pathogenicity	Synthesis and characterization of human alpha-defensins 4-6.	Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W	J Pept Res	10.1111/j.1399-3011.2004.00179.x	2004	*
Pathogenicity	Comparison of methods for antimicrobial susceptibility testing and MIC values for pleuromutilin drugs for Brachyspira hyodysenteriae isolated in Germany.	Rohde J, Kessler M, Baums CG, Amtsberg G	Vet Microbiol	10.1016/j.vetmic.2004.03.023	2004	*
Metabolism	Differences in biofilm and planktonic cell mediated reduction of metalloid oxyanions.	Harrison JJ, Ceri H, Stremick C, Turner RJ	FEMS Microbiol Lett	10.1016/j.femsle.2004.05.005	2004	*
Enzymology	In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.	Ganiere JP, Medaille C, Etore F	Res Vet Sci	10.1016/j.rvsc.2004.02.002	2004	*
Cultivation	Synthesis and antibacterial activities of new bis-benzimidazoles.	Kucukbay H, Durmaz R, Okuyucu N, Gunal S, Kazaz C	Arzneimittelforschung	10.1055/s-0031-1296938	2004	*
Pathogenicity	Bacterial reduction by cell salvage washing and leukocyte depletion filtration.	Waters JH, Tuohy MJ, Hobson DF, Procop G	Anesthesiology	10.1097/00000542-200309000-00021	2003	*
Pathogenicity	Inhibition of the anti-staphylococcal activity of the antiseptic polihexanide by mucin.	Ansorg R, Rath PM, Fabry W	Arzneimittelforschung	10.1055/s-0031-1297121	2003	*
Enzymology	Target site bacterial killing of cefpirome and fosfomycin in critically ill patients.	Zeitlinger MA, Marsik C, Georgopoulos A, Muller M, Heinz G, Joukhadar C	Int J Antimicrob Agents	10.1016/s0924-8579(03)00047-5	2003	*
Pathogenicity	Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus areus.	Olsson-Liljequist B, Koljalg S, Karlsson I, Kronvall G	APMIS	10.1034/j.1600-0463.2002.1101002.x	2002	*
Pathogenicity	The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.	Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J	J Biol Chem	10.1074/jbc.M203907200	2002	*
Pathogenicity	Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts.	Cetinkaya E, Denizci A, Ozdemir I, Ozturk HT, Karaboz I, Cetinkaya B	J Chemother	10.1179/joc.2002.14.3.241	2002	*
Phylogeny	Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry.	Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hunger F, Kronke M	Proteomics	10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V	2002	*
Pathogenicity	In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria.	Yorganci K, Krepel C, Weigelt JA, Edmiston CE	Eur J Clin Microbiol Infect Dis	10.1007/s10096-002-0719-z	2002	*
Pathogenicity	Inhibition, resistance development, and increased antibiotic and antimicrobial resistance caused by nutraceuticals.	Ward P, Fasitsas S, Katz SE	J Food Prot	10.4315/0362-028x-65.3.528	2002	*
Pathogenicity	Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.	Yanyali A, Cetin S, Talu H, Vahaboglu H	Ophthalmologica	10.1159/000050905	2001	*
Pathogenicity	Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).	Jones RN, Biedenbach DJ	Diagn Microbiol Infect Dis	10.1016/s0732-8893(01)00236-x	2001	*
Pathogenicity	Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities.	Kucukbay H, Durmaz R, Guven M, Gunal S	Arzneimittelforschung	10.1055/s-0031-1300057	2001	*
Pathogenicity	[Experimental study of antiseptic (tauroline, taurolidine) and antibiotic (sulmycin implant) drugs in vascular prosthesis infections in a standardized infection model].	Hernandez-Richter T, Schardey HM, Heiss MM, Lohlein F, Schildberg FW	Zentralbl Chir	10.1055/s-2001-14758	2001	*
Pathogenicity	Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar.	Dominguez MC, de La Rosa M, Borobio MV	J Antimicrob Chemother	10.1093/jac/47.4.391	2001	*
Pathogenicity	Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.	White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA	Diagn Microbiol Infect Dis	10.1016/s0732-8893(00)00219-4	2001	*
Metabolism	In vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene] hydrazide in rats.	Gulerman NN, Oruc EE, Kartal F, Rollas S	Eur J Drug Metab Pharmacokinet	10.1007/BF03190075	2000	*
Pathogenicity	Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.	Todisco T, Eslami A, Baglioni S, Sposini T, Tascini C, Sommer E, Knoch M	J Aerosol Med	10.1089/jam.2000.13.11	2000	*
Cultivation	Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media.	Marshall SA, Kugler KC, Jones RN	Int J Antimicrob Agents	10.1016/s0924-8579(00)00180-1	2000	*
Pathogenicity	Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa.	Smith RP, Baltch AL, Franke MA, Michelsen PB, Bopp LH	J Antimicrob Chemother	10.1093/jac/45.4.483	2000	*
Pathogenicity	Antimicrobial activity of synthetic all-D mastoparan M.	Li ML, Liao RW, Qiu JW, Wang ZJ, Wu TM	Int J Antimicrob Agents	10.1016/s0924-8579(99)00127-2	2000	*
Pathogenicity	Staphylococcus aureus adherence to thrombin-treated endothelial cells is mediated by fibrinogen but not by platelets.	Shenkman B, Rubinstein E, Tamarin I, Dardik R, Savion N, Varon D	J Lab Clin Med	10.1016/s0022-2143(00)70019-9	2000	*
Pathogenicity	Decontamination of human sclera: an in vitro study.	Lucci LM, Yu MC, Hofling-Lima AL	Cornea	00003226-199909000-00011	1999	*
Pathogenicity	Antibacterial and antifungal activities of complexes of ruthenium (II).	Cetinkaya B, Ozdemir I, Binbasioglu B, Durmaz R, Gunal S	Arzneimittelforschung	10.1055/s-0031-1300457	1999	*
Pathogenicity	Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group.	Jones RN, Marshall SA, Erwin ME	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00093-5	1999	*
Pathogenicity	In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens.	Schwab U, Gilligan P, Jaynes J, Henke D	Antimicrob Agents Chemother	10.1128/AAC.43.6.1435	1999	*
Pathogenicity	New derivatives of benzimidazole and their antimicrobial activity.	Cetinkaya E, Alici B, Gok Y, Durmaz R, Gunal S	J Chemother	10.1179/joc.1999.11.2.83	1999	*
Pathogenicity	The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.	Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A	J Clin Microbiol	10.1128/JCM.37.6.1771-1776.1999	1999	*
Enzymology	Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.	Fernandez J, Barrett JF, Licata L, Amaratunga D, Frosco M	Antimicrob Agents Chemother	10.1128/AAC.43.3.667	1999	*
Pathogenicity	Antibacterial activity of peritoneal exudate in patients treated with 2 g cefotiam for surgical anti-microbial prophylaxis.	Miglioli PA, Schoeffel U, Gabroska E, Allerberger F	Chemotherapy	10.1159/000007108	1998	*

Search for species Staphylococcus aureus in external resources:
SILVA
BRENDA
PANGAEA
GBIF

Streptomyces sioyaensis strain B-5408

Staphylococcus aureus ATCC 29213